These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31996280)

  • 1. Validation of the SHEA/IDSA severity criteria to predict poor outcomes among inpatients and outpatients with
    Stevens VW; Shoemaker HE; Jones MM; Jones BE; Nelson RE; Khader K; Samore MH; Rubin MA
    Infect Control Hosp Epidemiol; 2020 May; 41(5):510-516. PubMed ID: 31996280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concordance of the SHEA-IDSA severity classification for Clostridium difficile infection and the ATLAS bedside scoring system in hospitalized adult patients.
    Mulherin DW; Hutchison AM; Thomas GJ; Hansen RA; Childress DT
    Infection; 2014 Dec; 42(6):999-1005. PubMed ID: 25129565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.
    Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K
    mBio; 2020 May; 11(3):. PubMed ID: 32371595
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk prediction for 30-day mortality among patients with
    Chiang HY; Huang HC; Chung CW; Yeh YC; Chen YC; Tien N; Lin HS; Ho MW; Kuo CC
    Antimicrob Resist Infect Control; 2019; 8():175. PubMed ID: 31749963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Clostridioides difficile Infection and Non-compliance with Treatment Guidelines in Adults in 10 US Geographical Locations, 2013-2015.
    Novosad SA; Mu Y; Winston LG; Johnston H; Basiliere E; Olson DM; Farley MM; Revis A; Wilson L; Perlmutter R; Holzbauer SM; Whitten T; Phipps EC; Dumyati GK; Beldavs ZG; Ocampo VLS; Davis CM; Kainer M; Gerding DN; Guh AY
    J Gen Intern Med; 2020 Feb; 35(2):412-419. PubMed ID: 31768906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clostridioides difficile toxin B gen amplification cycle threshold as a predictor of severity].
    Sante L; Kohan R; Blanco-Hortas A; Díaz Z; Lecuona M
    Rev Chilena Infectol; 2022 Feb; 39(1):29-34. PubMed ID: 35735277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laxative Use Does Not Preclude Diagnosis or Reduce Disease Severity in Clostridiodes difficile Infection.
    White NC; Mendo-Lopez R; Papamichael K; Cuddemi CA; Barrett C; Daugherty K; Pollock N; Kelly CP; Alonso CD
    Clin Infect Dis; 2020 Sep; 71(6):1472-1478. PubMed ID: 31584632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients.
    Miller R; Morillas JA; Brizendine KD; Fraser TG
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Kidney Injury as a Severity Criteria for
    Carlson TJ; Gonzales-Luna AJ; Nebo K; Chan HY; Tran NT; Antony S; Lancaster C; Alam MJ; Begum K; Garey KW
    Open Forum Infect Dis; 2020 Nov; 7(11):ofaa476. PubMed ID: 33209956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does accepted definition of Clostridioides difficile infection (CDI) severity predict poor outcomes in older adults?
    Atamna A; Babich T; Margalit I; Avni T; Ben Zvi H; Raz NE; Yahav D; Bishara J
    Aging Clin Exp Res; 2022 Mar; 34(3):583-589. PubMed ID: 34426944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External Validation and Comparison of Clostridioides difficile Severity Scoring Systems.
    Perry DA; Shirley D; Micic D; Patel PC; Putler R; Menon A; Young VB; Rao K
    Clin Infect Dis; 2022 Jun; 74(11):2028-2035. PubMed ID: 34459885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile infection and limitations of markers for severity in patients with hematologic malignancy.
    Wang MS; Evans CT; Rodriguez T; Gerding DN; Johnson S
    Infect Control Hosp Epidemiol; 2013 Feb; 34(2):127-32. PubMed ID: 23295558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of mortality attributable to Clostridium difficile infection in patients with underlying malignancy.
    Yoon YK; Kim MJ; Sohn JW; Kim HS; Choi YJ; Kim JS; Kim ST; Park KH; Kim SJ; Kim BS; Shin SW; Kim YH; Park Y
    Support Care Cancer; 2014 Aug; 22(8):2039-48. PubMed ID: 24595407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe Clostridium difficile infection: incidence and risk factors at a tertiary care university hospital in Vienna, Austria.
    Starzengruber P; Segagni Lusignani L; Wrba T; Mitteregger D; Indra A; Graninger W; Presterl E; Diab-Elschahawi M
    Wien Klin Wochenschr; 2014 Jul; 126(13-14):427-30. PubMed ID: 24903143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Connecticut medical providers' concordance with 2017 IDSA/SHEA
    Luc CM; Olson D; Banach DB; Clogher P; Hadler J
    Infect Control Hosp Epidemiol; 2021 May; 42(5):549-556. PubMed ID: 33234174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a simple and robust model to predict 30-day mortality in patients with
    Katzer KC; Hagel S; Reuken PA; Bruns T; Stallmach A
    BMJ Open Gastroenterol; 2020 Sep; 7(1):. PubMed ID: 32912845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of Clostridioides difficile infections among young and middle-aged adults: Veterans Health Administration.
    Russo EM; Kuntz J; Yu H; Smith J; Hauser RG; Halchenko Y; Young-Xu Y
    Infect Control Hosp Epidemiol; 2019 Sep; 40(9):997-1005. PubMed ID: 31322101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults.
    Johnson S; Lavergne V; Skinner AM; Gonzales-Luna AJ; Garey KW; Kelly CP; Wilcox MH
    Clin Infect Dis; 2021 Sep; 73(5):755-757. PubMed ID: 34492699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults.
    Johnson S; Lavergne V; Skinner AM; Gonzales-Luna AJ; Garey KW; Kelly CP; Wilcox MH
    Clin Infect Dis; 2021 Sep; 73(5):e1029-e1044. PubMed ID: 34164674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of Clinical Risk Models for Clostridioides difficile
    Madden GR; Petri WA; Costa DVS; Warren CA; Ma JZ; Sifri CD
    Antimicrob Agents Chemother; 2022 Jul; 66(7):e0067622. PubMed ID: 35727061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.